Source link : https://www.newshealth.biz/health-news/blood-tests-for-alzheimers-are-hereare-clinicians-ready/
With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising alternative to amyloid PET scans and cerebrospinal fluid (CSF) analysis and are being increasingly used in clinical practice to support an AD diagnosis. Recently, an expert workgroup convened […]
Author : News Health
Publish date : 2024-10-24 13:32:57
Copyright for syndicated content belongs to the linked Source.
